{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:51:55Z","timestamp":1789732315122,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ekir.2022.05.033","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T13:07:11Z","timestamp":1654693631000},"page":"2059-2070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-3156","authenticated-orcid":false,"given":"Glen","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jose","family":"Garcia Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-2024","authenticated-orcid":false,"given":"Juan Jesus","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-6710","authenticated-orcid":false,"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J.L.","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hungta","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail N.","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2022.05.033_bib1","first-page":"1","article-title":"KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2022.05.033_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2022.05.033_bib3","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","article-title":"A\u00a0single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"34","author":"Jager","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2022.05.033_bib4","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2022.05.033_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081702","article-title":"Novel biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome","volume":"18","author":"Rysz","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2022.05.033_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12325-020-01568-8","article-title":"Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic review","volume":"38","author":"Murton","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.ekir.2022.05.033_bib7","first-page":"67","article-title":"Estimated glomerular filtration rate versus albuminuria in the assessment of kidney function: what\u2019s more important?","volume":"35","author":"Polkinghorne","year":"2014","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.ekir.2022.05.033_bib8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.05.033_bib9","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2022.05.033_bib10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.05.033_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.05.033_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/2054358119892372","article-title":"The risk of stroke and stroke type in patients with atrial fibrillation and chronic kidney disease","volume":"6","author":"Mace-Brickman","year":"2019","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.ekir.2022.05.033_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18169","article-title":"Clinical characteristics of and risk factors for chronic kidney disease among adults and children: an analysis of the CURE-CKD Registry","volume":"2","author":"Tuttle","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ekir.2022.05.033_bib14","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US Renal Data System 2019 annual data report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2022.05.033_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110535","article-title":"Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease)","volume":"9","author":"Szczech","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2022.05.033_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s12325-020-01609-2","article-title":"Clinical outcomes and healthcare resource utilization in a real-world population reflecting the DAPA-CKD Trial participants","volume":"38","author":"Olufade","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.ekir.2022.05.033_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12875-015-0235-8","article-title":"Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study","volume":"16","author":"Fraser","year":"2015","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.ekir.2022.05.033_bib18","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s12325-020-01607-4","article-title":"Costs and healthcare resource use associated with risk of cardiovascular morbidity in patients with chronic kidney disease: evidence from a systematic literature review","volume":"38","author":"Darlington","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.ekir.2022.05.033_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12325-021-02006-z","article-title":"Treatments for chronic kidney disease: A systematic literature review of randomized controlled trials","volume":"39","author":"Garcia Sanchez","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.ekir.2022.05.033_bib20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ckj\/sfab046","article-title":"Methods and rationale of the DISCover CKD global observational study","volume":"14","author":"Pecoits-Filho","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2022.05.033_bib21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/0269881120936501","article-title":"Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: an electronic health records network study","volume":"34","author":"Harrison","year":"2020","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.ekir.2022.05.033_bib22","series-title":"TriNetX","year":"2022"},{"key":"10.1016\/j.ekir.2022.05.033_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00067","article-title":"Using a federated network of real-world data to optimize clinical trials operations","volume":"2","author":"Topaloglu","year":"2018","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.ekir.2022.05.033_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ekir.2022.05.033_bib25","series-title":"CPRD","year":"2022"},{"key":"10.1016\/j.ekir.2022.05.033_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/oxfordjournals.aje.a115507","article-title":"A\u00a0simple method to calculate the confidence interval of a standardized mortality ratio (SMR)","volume":"131","author":"Ulm","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ekir.2022.05.033_bib27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2022.05.033_bib28","first-page":"S151","article-title":"11. Microvascular complications and foot care: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2022.05.033_bib29","doi-asserted-by":"crossref","first-page":"F780","DOI":"10.1152\/ajprenal.00518.2020","article-title":"SGLT2 inhibitors: diabetic kidney disease and beyond","volume":"319","author":"Staruschenko","year":"2020","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2022.05.033_bib30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.05.033_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.05.033_bib32","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.05.033_bib33","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2022.05.033_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.kint.2016.09.037","article-title":"Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality","volume":"91","author":"Carrero","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.05.033_bib35","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41591-019-0627-8","article-title":"Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease","volume":"25","author":"Lees","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2022.05.033_bib36","series-title":"Chronic kidney disease in adults: assessment and management","year":"2014"},{"key":"10.1016\/j.ekir.2022.05.033_bib37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/ckj\/sfw044","article-title":"Incident chronic kidney disease: trends in management and outcomes","volume":"9","author":"Perkins","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2022.05.033_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028062","article-title":"Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRD","volume":"9","author":"Feakins","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ekir.2022.05.033_bib39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2022.05.033_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000516280","article-title":"Incidence of uncommon clinical events in USA patients with dialysis-dependent and nondialysis-dependent chronic kidney disease: analysis of electronic health records from TriNetX","volume":"145","author":"Sultan","year":"2021","journal-title":"Nephron"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922014358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922014358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:41:06Z","timestamp":1762832466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024922014358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2468024922014358"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2022.05.033","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2022.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}